mitoXANTRONE
- Product NDC
- 0703-4686
- 11-digit product format
- 007034686
- Labeler code
- 0703
- Product ID
- 0703-4686_4e9bdbc5-b9de-4e8e-9b0c-2f969a5a9c1e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- mitoXANTRONE
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- Teva Parenteral Medicines, Inc.
- Application
- ANDA077356
- Marketing category
- ANDA
- Marketing start
- 2006-04-11
- Marketing end
- 0000-00-00
- Substance
- MITOXANTRONE HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0703-4686-01 | 00703468601 | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-4686-01) > 15 mL in 1 VIAL, MULTI-DOSE | 2006-04-11 | 0000-00-00 | No | No | Current |